Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» clinical trials
clinical trials
Recruiting trials dominated in 2024
Clinical Trials Arena
Mon, 03/31/25 - 10:57 pm
clinical trials
clinical trial recruitment
Merck's Winrevair slashes mortality-morbidity risk by 76%
Fierce Pharma
Mon, 03/31/25 - 11:02 am
Merck
PAH
Winrevair
clinical trials
Eli Lilly’s lepodisiran cuts lipoprotein(a) by 93.9% in Phase II trial
Clinical Trials Arena
Mon, 03/31/25 - 10:55 am
Eli Lilly
lepodisiran
clinical trials
heart disease
Vertex halts development of diabetes cell therapy after trial failure
Clinical Trials Arena
Mon, 03/31/25 - 10:51 am
Vertex Pharmaceuticals
VX-264
type 1 diabetes
cell therapy
clinical trials
Corcept reports key trial success in ovarian cancer treatment
Investing.com
Mon, 03/31/25 - 10:14 am
Corcept Therapeutics
ovarian cancer
clinical trials
relacorilant
nab-paclitaxel
Acumen concludes enrolment in Phase II trial of sabirnetug for Alzheimer’s
Clinical Trials Arena
Thu, 03/27/25 - 11:12 am
Acumen Pharmaceuticals
clinical trials
sabirnetug
Alzheimer's disease
IGC Pharma posts promising interim data for Alzheimer’s therapy
Clinical Trials Arena
Thu, 03/27/25 - 11:10 am
IGC
clinical trials
IGC-AD1
Alzheimer's disease agitation
Zetomipzomib Yields Positive Phase IIa Trial Results in Autoimmune Hepatitis
Xtalks
Wed, 03/26/25 - 10:23 pm
Kezar Life Sciences
zetomipzomib
clinical trials
autoimmune hepatitis
Axsome touts success of phase 3 trial of Sunosi in ADHD, adding to 'string of recent wins'
Fierce Pharma
Tue, 03/25/25 - 09:51 pm
Axsome Therapeutics
ADHD
clinical trials
Sunosi
Cassava Sciences' controversial Alzheimer's drug fails in second late-stage study
Reuters
Tue, 03/25/25 - 11:24 am
Cassava Sciences
clinical trials
simufilam
Alzheimer's disease
FDA aligns with Imunon’s Phase III trial protocol for ovarian cancer treatment
Clinical Trials Arena
Tue, 03/25/25 - 11:21 am
Imunon
FDA
clinical trials
IMNN-001
ovarian cancer
MacroGenics axes ADC drug following Phase II failure in prostate cancer
Clinical Trials Arena
Tue, 03/25/25 - 10:27 am
Macrogenics
clinical trials
prostate cancer
vobra duo
Verve gets FDA green light to expand base editing trial into US
BioPharma Dive
Tue, 03/25/25 - 10:22 am
Verve Therapeutics
gene editing
clinical trials
VERVE-102
cholesterol
Phase 3 readout puts Opthea at risk of insolvency
Pharmaphorum
Mon, 03/24/25 - 10:57 am
Opthea
clinical trials
wet age-related macular degeneration
sozinibercept
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
Fierce Biotech
Fri, 03/21/25 - 11:39 am
Macrogenics
vobra duo
clinical trials
Potential impacts of the US withdrawal from the WHO on clinical trials globally
Clinical Trials Arena
Fri, 03/21/25 - 11:38 am
clinical trials
WHO
Public Health
Neurocrine Biosciences debuts new data for effectiveness of Ingrezza
Clinical Trials Arena
Thu, 03/20/25 - 09:50 pm
Neurocrine Biosciences
clinical trials
Ingrezza
Funding drought: how can biotech and biopharma keep trials running?
Clinical Trials Arena
Thu, 03/20/25 - 11:12 am
funding
biotech
clinical trials
Roche's gantenerumab 'shows sign of preventing Alzheimer's dementia'
Pharmaphorum
Thu, 03/20/25 - 09:56 am
Roche
gantenerumab
clinical trials
Alzheimer's disease
AstraZeneca’s $1bn hypoparathyroidism drug achieves success at Phase III
Clinical Trials Arena
Tue, 03/18/25 - 11:16 am
AstraZeneca
clinical trials
hypoparathyroidism
eneboparatide
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »